{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-061028","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.335716+00:00","generated_at":"2026-05-31T20:57:13.314146+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ABVC BioPharma receives Nasdaq deficiency notice for bid price below $1.00","bullets":["Received Nasdaq notice on July 10, 2024 for non-compliance with minimum $1.00 bid price rule over 30 consecutive days.","Compliance deadline is January 6, 2025; can regain if bid price closes at $1.00+ for 10 business days.","If not cured, may qualify for additional 180-day period if other initial listing standards are met.","Company may consider a reverse stock split to cure the deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-061028","json":"https://secwatch.observer/filing/0001213900-24-061028.json","markdown":"https://secwatch.observer/filing/0001213900-24-061028.md","text":"https://secwatch.observer/filing/0001213900-24-061028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024061028/0001213900-24-061028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024061028/ea0209346-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:57:13.314146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}